The Online Investor
BioTelemetry Inc (BEAT)

BioTelemetry is a remote medical technology company focused on delivery of health information. Co. provides remote cardiac monitoring, centralized core laboratory services, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. Co.'s segments are: Healthcare, which is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices; and Research, which is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, consulting and data management services for drug and medical device trials.
Company Name: 
BioTelemetry Inc
Quotes delayed 20 minutes

Email EnvelopeFree BEAT Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.40 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
BEAT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

BioTelemetry Inc (BEAT) Page | The Online Investor Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.